<?xml version="1.0" encoding="UTF-8"?>
<p id="p0080">Accordingly, analysis of the different fusion loop homologies suggests replacing SARS-CoV-2 amino acids 816–855 with HCoV-229E amino acids 923–982 may be candidate for an attenuated alpha–beta SARS-CoV-2/COVID-19 vaccine that would be able to generate host immunity, yet lower the pathogenicity to level of HCoV-229E.</p>
